Pulmonology & Respiratory Clinical Calculators
Evidence-based pulmonology calculators for chronic obstructive pulmonary disease (COPD) staging, asthma control assessment, dyspnea evaluation, and acute respiratory distress syndrome (ARDS) classification.
Why This Matters
Chronic respiratory diseases affect over 545 million people worldwide, with COPD as the third leading cause of death globally. Asthma affects 262 million people, causing significant morbidity and healthcare utilization. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) reports that COPD is underdiagnosed, with up to 70% of cases undetected in some regions. Standardized assessment tools like GOLD staging, ACT, MMRC, and CAT are essential for objective disease classification, treatment guidance, and monitoring response to therapy. The ARDS Berlin definition standardized the diagnosis of acute respiratory distress syndrome, which affects 10% of ICU admissions worldwide with mortality rates of 35-46%. Using these validated tools ensures consistent, evidence-based care across respiratory medicine.
When to Use
Use GOLD Staging for COPD severity classification based on FEV1 and exacerbation history. Use ACT (Asthma Control Test) for asthma control assessment in patients aged 12+. Use MMRC (Modified Medical Research Council) Dyspnea Scale for quantifying breathlessness in respiratory disease. Use CAT (COPD Assessment Test) for comprehensive COPD symptom impact assessment. Use ARDS Berlin Criteria for diagnosing and classifying acute respiratory distress syndrome in ICU patients.
Available Pulmonology & Respiratory Calculators
GOLD Staging
The GOLD COPD Staging system, developed by the Global Initiative for Chronic Obstructive Lung Disease (GOLD), is the internationally accepted standard for classifying COPD severity and guiding treatment decisions based on airflow limitation, symptom burden, and exacerbation history.
Calculate →ACT
The Asthma Control Test (ACT) is a validated, patient-completed questionnaire that assesses asthma control over the preceding four weeks. It is widely used in clinical practice and research to identify patients with poorly controlled asthma who may benefit from treatment adjustment.
Calculate →mMRC Scale
The Modified Medical Research Council (mMRC) Dyspnea Scale is a simple, validated tool for grading the severity of breathlessness in daily activities. It is widely used in COPD assessment and other respiratory diseases to quantify the impact of dyspnea on functional capacity.
Calculate →CAT
The COPD Assessment Test (CAT) is a validated, patient-completed questionnaire that quantifies the impact of chronic obstructive pulmonary disease (COPD) on a patient's health status and daily life. It provides a comprehensive assessment of symptom burden across eight domains.
Calculate →ARDS Berlin
The ARDS Berlin Definition, published in 2012 by the ARDS Definition Task Force, provides the current international consensus criteria for diagnosing and classifying acute respiratory distress syndrome (ARDS) in adults. It replaced the earlier American-European Consensus Conference (AECC) definition from 1994.
Calculate →A-a Gradient
The A-a gradient (alveolar-arterial gradient) measures the difference between alveolar oxygen concentration (PAO2) and arterial oxygen concentration (PaO2), helping differentiate between hypoventilation and intrinsic lung pathology as causes of hypoxemia.
Calculate →FEV1/FVC Ratio
The FEV1/FVC ratio is a key spirometric parameter used to differentiate obstructive lung disease (COPD, asthma) from restrictive lung disease (pulmonary fibrosis, chest wall disorders).
Calculate →BODE Index
The BODE Index is a multidimensional grading system that predicts mortality in patients with chronic obstructive pulmonary disease (COPD). It combines four variables: body mass index (BMI), degree of airflow obstruction (FEV1), dyspnea severity (MMRC), and exercise capacity (6-minute walk distance). The index provides superior prognostic information compared to FEV1 alone.
Calculate →6MWT Calculator
The 6-Minute Walk Test (6MWT) measures the distance a patient can walk in 6 minutes and is used to assess functional exercise capacity, monitor disease progression, and evaluate treatment response in cardiorespiratory conditions.
Calculate →PESI Score
The Pulmonary Embolism Severity Index (PESI) is a validated clinical prediction rule that stratifies patients with acute pulmonary embolism into five risk classes (I-V) based on 30-day mortality, using 11 clinical variables including age, sex, comorbidities, vital signs, and mental status.
Calculate →sPESI Score
The simplified Pulmonary Embolism Severity Index (sPESI) is a validated clinical tool that predicts 30-day mortality in patients with acute pulmonary embolism (PE), helping guide the decision between outpatient versus inpatient management.
Calculate →DECAF
The DECAF Score is a validated clinical prediction tool for estimating in-hospital mortality risk in patients admitted with acute exacerbation of COPD (AECOPD). It combines five easily assessed clinical parameters: Dyspnea (eMRCD score), Eosinopenia, Consolidation on chest X-ray, Acidemia, and atrial Fibrillation. The score helps clinicians stratify patients for appropriate level of care and guide treatment intensity.
Calculate →Berlin Questionnaire
The Berlin Questionnaire is a validated screening tool to identify patients at high risk for obstructive sleep apnea (OSA). It assesses three symptom categories: snoring/breathing pauses, daytime sleepiness, and hypertension/high BMI.
Calculate →
Clinical Guidelines
- GOLD 2024 Strategy Report for Diagnosis, Management, and Prevention of COPD
- GINA 2024 Global Strategy for Asthma Management and Prevention
- ARDS Definition Task Force. Acute Respiratory Distress Syndrome: The Berlin Definition. JAMA 2012.
- ATS/ERS Standards for the Diagnosis and Management of COPD (2024)
Frequently Asked Questions
Integrate these tools into your clinic workflow with Tabeeb+
Try Tabeeb+ for Your Clinic